This study proposes "NeuroFusion," a distinctive predictive technique intended to boost Alzheimer's disease (also known as AD) prediction accuracy. NeuroFusion integrates aspects obtained using the VGG16 and InceptionV3 deep neural network structures, making use of each of their strengths for gathering rich positional knowledge and multiple scale characteristics using neuroimaging images. The technique of transfer learning is employed to improve these already trained models utilizing varied datasets that include inherited, medical, and neuroimaging imagery. Sophisticated merging methods are subsequently employed to bring together the collected features, which increases the framework's selective performance. Experimental scrutiny of the dataset suggests NeuroFusion's enhanced performance compared to both standalone models and known benchmarks, as demonstrated by initiatives like reliability, precision, recollection, and F1 progress. Visualization instruments give additional insight into the framework's method of decision-making and highlight key biomarkers that contribute to AD assessment. NeuroFusion is a possible leap forward in Alzheimer's disease forecasting, providing increased accuracy and endurance for early identification and involvement in Alzheimer's disease ( AD ) therapy